Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Phthalazine derivatives as inhibitors of PARP1, PARP2, and/or tubulin useful for the treatment of cancer

Phthalazine derivatives as inhibitors of PARP1, PARP2, and/or tubulin useful for the treatment of cancer

US Patent 10640493 · Granted May 5, 2020

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Compounds and compositions for the treatment of cancer2025
Compounds and compositions for the treatment of cancer2025
Compounds and compositions for the treatment of cancer2025
Phthalazine derivatives as inhibitors of PARP1, PARP2, and/or tubulin useful for2024
Phthalazine derivatives as inhibitors of PARP1, PARP2, and/or tubulin useful for2024
Phthalazine derivatives as inhibitors of PARP1, PARP2, and/or tubulin useful for2024
Phthalazine derivatives as inhibitors of PARP1, PARP2, and/or tubulin useful for2024
Anti-cancer/anti-fibrosis compounds2024
Anti-cancer compounds2023
Anti-cancer compounds2023
Anti-cancer compounds2023
MEK inhibitors and methods of their use2023